Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
A phase 3 trial of a higher-dose CagriSema formulation at 2.4/7.2 mg is planned for initiation in the second half of 2026, and the REDEFINE 11 trial, exploring CagriSemas full weight-loss potential, is expected to report data in the first half of 2027
Patients receiving an antipsychotic should be treated with structured lifestyle modifications to promote weight loss and weight gain prevention
C.PandolfiP
Fatigue , dizziness , and acid reflux may occur during these transition periods but usually resolve within one to two weeks at each new dose level
Murray, J
US$ 26.55
US$ 28.62
US$ 22.07
US$ 24.29
US$ 24.90
US$ 28.12
